Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in J Clin Invest

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    September 2021
  1. ZHANG Z, Sun Z, Fu J, Lin Q, et al
    Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.
    J Clin Invest. 2021 Sep 9. pii: e146643. doi: 10.1172/JCI146643.
    PubMed     Abstract available


    August 2021
  2. MOE OW
    A generic crystallopathic model for chronic kidney disease progression.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    July 2021
  3. ZHU K, Reiser J
    ALKBH1 reduces DNA N6-methyladenine to allow for vascular calcification in chronic kidney disease.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    June 2021
  4. SHIIZAKI K, Tsubouchi A, Miura Y, Seo K, et al
    Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.
    J Clin Invest. 2021 Jun 29. pii: e145693. doi: 10.1172/JCI145693.
    PubMed     Abstract available


  5. SOLAGNA F, Tezze C, Lindenmeyer MT, Lu S, et al
    Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    May 2021
  6. OUYANG L, Su X, Li W, Tang L, et al
    ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.
    J Clin Invest. 2021 May 18. pii: 146985. doi: 10.1172/JCI146985.
    PubMed     Abstract available


    March 2021
  7. KAWANISHI K, Saha S, Diaz S, Vaill M, et al
    Evolutionary conservation of human ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: